Search

Karyopharm Therapeutics Inc

Открыт

СекторЗдравоохранение

2 0.5

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.96

Макс.

2.04

Ключевые показатели

By Trading Economics

Доход

80M

-22M

Продажи

987K

35M

Прибыль на акцию

-4.32

Рентабельность продаж

-63.857

Сотрудники

228

EBITDA

8M

-9.8M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+261.81% upside

Дивиденды

By Acuity

Следующий отчет о доходах

2 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-154M

44M

Предыдущая цена открытия

1.5

Предыдущая цена закрытия

2

Новостные настроения

By Acuity

92%

8%

323 / 340 Рейтинг в Healthcare

Karyopharm Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 авг. 2026 г., 23:11 UTC

Karyopharm Therapeutics Inc shares are rising in after-market trading, showing a modest upward trend since Thursday's close despite recent significant declines.

12 авг. 2026 г., 19:56 UTC

Karyopharm Therapeutics Inc shares are lower today, retracing from an early high amid broader market conditions and geopolitical tensions. No specific news was identified.

11 авг. 2026 г., 20:01 UTC

Karyopharm Therapeutics Inc is trading higher today, having reached a peak earlier in the session. The stock remains below its 20-day moving average.

10 авг. 2026 г., 20:06 UTC

Karyopharm Therapeutics Inc shares are lower today, reversing an early gain and reaching a mid-morning low, with no specific news identified for the decline.

7 авг. 2026 г., 23:31 UTC

Karyopharm Therapeutics shares are lower in after-market hours, following a decline earlier despite gains in major tech stocks. No specific news was identified.

6 авг. 2026 г., 23:21 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours. The asset is trading below its 20-day moving average and near the lower end of its one-month range.

5 авг. 2026 г., 23:01 UTC

Karyopharm Therapeutics shares are lower in after-market hours, continuing a three-session decline amid broader market weakness from disappointing U.S. employment data.

4 авг. 2026 г., 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market trading, though no specific news explains the movement. Broader market optimism may be influencing risk assets.

3 авг. 2026 г., 23:41 UTC

News

Karyopharm Therapeutics shares are lower in after-market hours following the grant of restricted stock units to a new employee, raising potential dilution concerns.

1 авг. 2026 г., 00:01 UTC

Karyopharm Therapeutics Inc shares are higher in after-market hours, reaching their highest cumulative return of the day despite recent underperformance.

31 июл. 2026 г., 23:31 UTC

Karyopharm Therapeutics shares rose during after-market hours, continuing a recovery from an earlier low. The stock remains below its 20-day moving average.

30 июл. 2026 г., 23:41 UTC

Social Media
Event
News

Karyopharm Therapeutics shares fell sharply after its Phase 3 trial for selinexor failed to meet key endpoints, leading to a shift in focus away from endometrial cancer.

29 июл. 2026 г., 19:27 UTC

Macro Event

Karyopharm Therapeutics shares are lower as investor anxiety rises following the Federal Reserve's decision to maintain interest rates amid global uncertainties.

27 июл. 2026 г., 19:07 UTC

Karyopharm Therapeutics Inc shares are lower during Monday's trading session, reflecting ongoing weakness and broader market trends amid declining crude oil prices.

24 июл. 2026 г., 19:42 UTC

Karyopharm Therapeutics Inc. shares are higher during Friday's session, continuing a notable advance since Thursday, despite broader market challenges.

23 июл. 2026 г., 09:01 UTC

Karyopharm Therapeutics Inc shares are higher in pre-market trading, continuing an upward trend since Wednesday, despite recent volatility and no specific news.

22 июл. 2026 г., 18:41 UTC

Social Media

Karyopharm Therapeutics shares are declining amid market caution and rising crude oil prices. RBC Capital reaffirmed its Outperform rating with a $16 price target.

21 июл. 2026 г., 20:12 UTC

Karyopharm Therapeutics shares are lower in after-market hours, with no specific news driving the decline despite positive sentiment in U.S. markets.

20 июл. 2026 г., 23:01 UTC

News

Karyopharm Therapeutics shares fell in after-market hours following the announcement of a leadership cash retention program aimed at key executives.

Сравнение c конкурентами

Изменение цены

Karyopharm Therapeutics Inc Прогноз

Целевая цена

By TipRanks

261.81% рост

Прогноз на 12 месяцев

Средняя 7.2 USD  261.81%

Максимум 11 USD

Минимум 3 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Karyopharm Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

6 ratings

3

Покупка

3

Удержание

0

Продажа

Настроения

By Acuity

323 / 340Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

help-icon Live chat